| (Values in U.S. Thousands) | Dec, 2018 | Dec, 2017 | Feb, 2026 | Feb, 2026 | Feb, 2026 |
| Sales | 111,014 | 89,218 | 0 | 0 | 0 |
| Sales Growth | +24.43% | unch | unch | unch | unch |
| Net Income | 18,735 | 13,196 | 0 | 0 | 0 |
| Net Income Growth | +41.97% | unch | unch | unch | unch |
Eagle Health Holdings Ltd (EHH.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Eagle Health Holdings Ltd is a vertically integrated health and nutritional products company. It develops, manufactures and distributes products across provinces in China. Eagle Health produces a range of traditional Chinese medicine and Western nutritional products including amino acids, protein supplements, lozenges and dendrobium oil. The group operates predominately in one geographical area where sales revenue is generated, that is from the People's Republic of China.
Fiscal Year End Date: 12/31